cannabis indica

Transtornos de Comportamento

termo de indexação original: Behavioral Disorders

O acervo do Cannabis Indica reúne 192 estudos científicos que tocam a condição Transtornos de Comportamento, publicados entre 2002 e 2024. Pela leitura automatizada, 99 (52%) foram classificados como favoráveis, 38 (20%) como inconclusivos e 55 (29%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (84 estudos), seguido de estudo em animais (42). Os compostos mais presentes são Endocanabinoide (não especificado), Anandamida (AEA) e Hidrolase de Amidas de Ácidos Graxos (FAAH). Aparece com frequência ao lado de Disfunção Cognitiva, Ansiedade e Efeitos Adversos da Cannabis.

Estudos indexados
192
Período coberto
2002–2024
Favoráveis
99 · 52%
Inconclusivos
38 · 20%
Desfavoráveis
55 · 29%
Termo original
Behavioral Disorders

O acervo em números

Tipo de estudo

Metanálise84
Estudo em Animais42
Ensaio Clínico32
Ensaio Clínico Duplo-Cego25
Metanálise Clínica9

Direção do resultado

Favorável99
Inconclusivo38
Desfavorável55

Por década

2000s6
2010s45
2020s141

192 estudos

Filtrar e buscar no acervo →
  1. 2024

    An intervention based on Well-Being Therapy to prevent alcohol use and other unhealthy lifestyle behaviors among students: a three-arm cluster randomized controlled trial

  2. 2024

    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

    DesfavorávelMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+4
  3. 2024

    Cannabidiol for behavior symptoms in Alzheimer’s disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial

    FavorávelEnsaio ClínicoAnsiedadeDoença de AlzheimerDemênciaCBD Farmacêutico
  4. 2024

    Cannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents: a systematic review

    InconclusivoMetanálise ClínicaDisfunção CognitivaAutismo
  5. 2024

    Cognitive-behavioral therapies in the management of adolescents with cannabis use disorder (CUD): A systematic review

    FavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDisfunção Cognitiva
  6. 2024

    Systematic review: the impact of maternal pre-and postnatal cannabis use on the behavioral and emotional regulation in early childhood

  7. 2024

    The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study

  8. 2024

    The Interplay of Sleep Quality, Mental Health, and Sociodemographic and Clinical Factors among Italian College Freshmen

    DesfavorávelEnsaio ClínicoDependência QuímicaAnsiedadeDepressão+2
  9. 2023

    A systematic review of cannabidiol trials in neurodevelopmental disorders

    FavorávelMetanálise ClínicaDorInflamaçãoAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+10
  10. 2023

    Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review

  11. 2023

    Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  12. 2023

    Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

    FavorávelMetanáliseDisfunção CognitivaPsicoseEsquizofreniaAnandamida (AEA)
  13. 2023

    Cannabidiol repairs behavioral and brain disturbances in a model of fetal alcohol spectrum disorder

    FavorávelEstudo em AnimaisAnsiedadeDepressãoDisfunção CognitivaCanabicromeno (CBC)+4
  14. 2023

    Cannabidiol tempers alcohol intake and neuroendocrine and behavioural correlates in alcohol binge drinking adolescent rats. Focus on calcitonin gene-related peptide's brain levels

    FavorávelEstudo em AnimaisDependência QuímicaAnsiedadeDependência — Álcool
  15. 2023

    Delta-8-THC association with psychosis: A case report with literature review

  16. 2023

    Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

  17. 2023

    Gender differences in outcomes of early intervention services for first episode psychosis

    InconclusivoEnsaio ClínicoPsicoseEsquizofreniaTranstorno Bipolar+1
  18. 2023

    Induction of Anxiety-Like Phenotypes by Knockdown of Cannabinoid Type-1 Receptors in the Amygdala of Marmosets

    DesfavorávelEstudo em AnimaisAnsiedadeDepressãoDisfunção CognitivaEndocanabinoide (não especificado)+1
  19. 2023

    Instant Detection of Synthetic Cannabinoids on Physical Matrices, Implemented on a Low-Cost, Ultraportable Device

  20. 2023

    Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies

  21. 2023

    N-oleoyl glycine and N-oleoyl alanine attenuate alcohol self-administration and preference in mice

  22. 2023

    Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity

  23. 2023

    Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior

  24. 2023

    The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção CognitivaPsicose
  25. 2023

    The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial

    FavorávelEnsaio ClínicoAnsiedadeDisfunção Cognitiva
  26. 2023

    The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

  27. 2022

    A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ

    InconclusivoEnsaio Clínico Duplo-CegoInsônia e Distúrbios do SonoAutismoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  28. 2022

    A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeAutismoTDA e TDAHAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  29. 2022

    Abstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner

    InconclusivoEstudo em AnimaisTDA e TDAHEndocanabinoide (não especificado)
  30. 2022

    Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDepressãoDisfunção CognitivaPsicoseAnandamida (AEA)Palmitoiletanolamida (PEA)+3
  31. 2022

    Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC

  32. 2022

    Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands

    InconclusivoEstudo em AnimaisEndocanabinoide (não especificado)
  33. 2022

    Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1

    FavorávelEstudo em AnimaisAnsiedadeTEPTAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  34. 2022

    Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects

  35. 2022

    Anhedonia, apathy, pleasure, and effort-based decision-making in adult and adolescent cannabis users and controls

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  36. 2022

    Association between cannabis use and suicidal behavior: A systematic review of cohort studies

  37. 2022

    Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort

  38. 2022

    Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives

  39. 2022

    Behavioral effects on the offspring of rodent mothers exposed to Tetrahydrocannabinol (THC): A meta-analysis

  40. 2022

    Brain morphology predictors of alcohol, tobacco, and cannabis use in adolescence: A systematic review

  41. 2022

    Cannabidiol for the treatment of autism spectrum disorder: hope or hype?

  42. 2022

    Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study

  43. 2022

    Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model

    FavorávelEstudo em AnimaisEpilepsiaAutismoTDA e TDAH
  44. 2022

    Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice

  45. 2022

    Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

  46. 2022

    Cannabis and the Violent Crime Surge

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDepressãoPsicose+4
  47. 2022

    Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisTDA e TDAH
  48. 2022

    Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study

  49. 2022

    Clinical manifestations and serious adverse effects after cannabis use: role of age according to sex and coingestion of alcohol

    DesfavorávelEnsaio ClínicoDependência QuímicaEfeitos Adversos da CannabisPsicose+2
  50. 2022

    Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

  51. 2022

    Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies

  52. 2022

    Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women

    DesfavorávelEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)
  53. 2022

    Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior

    FavorávelEnsaio Clínico Duplo-CegoDisfunção CognitivaPsicose
  54. 2022

    Does cannabis use predict aggressive or violent behavior in psychiatric populations? A systematic review

    InconclusivoMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+4
  55. 2022

    E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

    DesfavorávelMetanáliseCâncerAnsiedadeDoenças Cardiovasculares (DCV)+16
  56. 2022

    Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial

    InconclusivoEnsaio ClínicoDorDependência — CannabisAnsiedade+4
  57. 2022

    Effects of endocannabinoid system modulation on social behaviour: A systematic review of animal studies

  58. 2022

    Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty

  59. 2022

    Endocannabinoid system contributions to sex-specific adolescent neurodevelopment

    InconclusivoMetanáliseDisfunção CognitivaEndocanabinoide (não especificado)
  60. 2022

    Herbal Approaches to Pediatric Functional Abdominal Pain

    InconclusivoMetanáliseDorInflamaçãoDor — CrônicaTHC Farmacêutico+10
  61. 2022

    Higher trait neuroticism is associated with greater fatty acid amide hydrolase binding in borderline and antisocial personality disorders

  62. 2022

    Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

  63. 2022

    Impact of cannabinoids on pregnancy, reproductive health and offspring outcomes

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTHC:CBD Farmacêutico+14
  64. 2022

    Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review

    FavorávelMetanáliseAnsiedadeDisfunção CognitivaInsônia e Distúrbios do Sono+1
  65. 2022

    In it together? The case for endocannabinoid–noradrenergic interactions in fear extinction

  66. 2022

    Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia

    FavorávelMetanáliseInflamaçãoDepressãoDisfunção Cognitiva+4
  67. 2022

    Influence of personality on acute smoked cannabis effects on simulated driving

    DesfavorávelEnsaio ClínicoEfeitos Adversos da Cannabis
  68. 2022

    Long-term effects of prenatal cannabis exposure: Pathways to adolescent and adult outcomes

    DesfavorávelMetanáliseDisfunção CognitivaPsicoseDependência — Opioides+5
  69. 2022

    Longitudinal effects of cannabis use on attentional processes in patients with first episode of psychosis

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDependência — CannabisPsicose+1
  70. 2022

    Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Swe /PS1ΔE9 Transgenic Female Mice

    FavorávelEstudo em AnimaisInflamaçãoAnsiedadeDisfunção Cognitiva+4
  71. 2022

    MicroRNA Regulation of the Environmental Impact on Adolescent Neurobehavioral Development: A Systematic Review

  72. 2022

    Neuroprotective effect of alpha-pinene is mediated by suppression of the TNF-α/NF-κB pathway in Alzheimer's disease rat model

    FavorávelEstudo em AnimaisInflamaçãoAnsiedadeDisfunção CognitivaMedicina Mente-Corpo+4
  73. 2022

    Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice

  74. 2022

    Potential Utility of Cannabidiol in Stress-Related Disorders

    FavorávelMetanáliseAnsiedadeTEPTEndocanabinoide (não especificado)
  75. 2022

    Prenatal cannabis exposure predicts attention problems, without changes on fMRI in adolescents

    DesfavorávelEnsaio ClínicoDisfunção CognitivaGestaçãoAlterações Cerebrais Neonatais+1
  76. 2022

    Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes

    InconclusivoMetanáliseDependência QuímicaDisfunção CognitivaSíndrome Metabólica+3
  77. 2022

    Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTetraidrocanabinol (THC)+12
  78. 2022

    Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeDisfunção Cognitiva
  79. 2022

    Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasCanabigerol (CBG)
  80. 2022

    Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward

    InconclusivoMetanáliseDorDoenças de Pele
  81. 2022

    Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report

  82. 2022

    The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study

  83. 2022

    The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDisfunção CognitivaTEPT
  84. 2022

    The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes

    FavorávelMetanálise ClínicaDorCâncerAnsiedade+5
  85. 2022

    The effect of β-caryophyllene on food addiction and its related behaviors: A randomized, double-blind, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoObesidadeEndocanabinoide (não especificado)
  86. 2022

    The effects of acute alcohol administration on circulating endocannabinoid levels in humans

  87. 2022

    The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study

  88. 2022

    The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use

  89. 2022

    The interactive effects of verapamil and CB1 cannabinoid receptor antagonist/inverse agonist, AM251 on passive avoidance learning and memory in rat

    FavorávelEstudo em AnimaisEndocanabinoide (não especificado)Canabinoides Sintéticos AM-x
  90. 2022

    The mental health of young people who are not in education, employment, or training: a systematic review and meta-analysis

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+3
  91. 2022

    Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials

    FavorávelMetanálise ClínicaDorDor — CrônicaEpilepsia+3
  92. 2021

    A Research Domain Criteria Approach to Gambling Disorder and Behavioral Addictions: Decision-Making, Response Inhibition, and the Role of Cannabidiol

  93. 2021

    A systematic, integrative review of the effects of the endocannabinoid system on inflammation and neurogenesis in animal models of affective disorders

  94. 2021

    Addictive behaviors across the menstrual cycle: a systematic review

    InconclusivoMetanáliseDependência QuímicaDistúrbios Menstruais
  95. 2021

    Adverse events of recreational cannabis use reported to the French addictovigilance network (2012-2017)

    DesfavorávelMetanáliseCâncerEfeitos Adversos da CannabisDependência — Cannabis+4
  96. 2021

    Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests

    FavorávelEstudo em AnimaisAnsiedadeTEPT2-Araquidonoilglicerol (2-AG)
  97. 2021

    Cannabidiol and mental health: possibilities, uncertainties, and controversies for addiction treatment

    InconclusivoMetanáliseDependência QuímicaAnsiedadeDepressão+10
  98. 2021

    Cannabidiol and Neurodevelopmental Disorders in Children

  99. 2021

    Cannabidiol for Mood Disorders: A Call for More Research

    DesfavorávelMetanáliseDorDor — CrônicaDepressão+3
  100. 2021

    Cannabidiol in the management of bruxism in behavioral variant of frontotemporal degeneration

    FavorávelMetanáliseDisfunção CognitivaDoenças Neurodegenerativas
  101. 2021

    Cannabigerol and cannabichromene in Cannabis sativa L.

  102. 2021

    Cannabinoid control of hippocampal functions: the where matters

  103. 2021

    Cannabis exposure during adolescence: A uniquely sensitive period for neurobiological effects

  104. 2021

    Cannabis Use in Pregnancy: A State of the Science Review

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDisfunção CognitivaGestação+1
  105. 2021

    Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase

  106. 2021

    Does cannabis use in adolescence predict self‐harm or suicide? Results from a Finnish Birth Cohort Study

    DesfavorávelMetanáliseEfeitos Adversos da CannabisPsicoseDependência — Opioides+5
  107. 2021

    Efficacy and safety of paediatric medicinal cannabis use: A scoping review

    DesfavorávelMetanáliseDorCâncerEpilepsiaTHC FarmacêuticoCBD Farmacêutico+6
  108. 2021

    Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisPsicose+1
  109. 2021

    Exploring the Relationship Between ADHD Symptoms and Daily Cannabis Consequences in Emerging Adulthood: The Role of Cannabis Motives

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisInsônia e Distúrbios do SonoTDA e TDAH
  110. 2021

    Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research

    FavorávelMetanáliseDorDependência QuímicaCâncer+16
  111. 2021

    Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping

  112. 2021

    Lifestyle Interventions Improving Cannabinoid Tone During COVID-19 Lockdowns May Enhance Compliance With Preventive Regulations and Decrease Psychophysical Health Complications

  113. 2021

    Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review

  114. 2021

    New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature

  115. 2021

    Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III

    DesfavorávelMetanáliseDorDependência — CannabisAnsiedade+2
  116. 2021

    Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence

  117. 2021

    Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study

    FavorávelMetanáliseAnsiedadeDepressãoTDA e TDAHCanabicromeno (CBC)
  118. 2021

    Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials

    InconclusivoMetanálise ClínicaAnsiedadeEsquizofreniaDependência — Nicotina+6
  119. 2021

    Potential therapeutic uses of cannabinoids to treat behavioural problems in children and adolescents with developmental disorders

    FavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+8
  120. 2021

    Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+2
  121. 2021

    Prevalence, sociodemographic variables, mental health condition, and type of drug use associated with suicide behaviors among people with substance use disorders: a systematic review and meta-analysis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisDepressão+5
  122. 2021

    Prosocial Effects of Nonpsychotropic Cannabis sativa in Mice

    FavorávelEstudo em AnimaisAnsiedade
  123. 2021

    Seizure frequency, quality of life, behavior, cognition, and sleep in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol

    FavorávelEnsaio ClínicoEpilepsiaInsônia e Distúrbios do SonoCBD Farmacêutico
  124. 2021

    Systematic review of the impact of cannabinoids on neurobehavioral outcomes in preclinical models of traumatic and nontraumatic spinal cord injury

  125. 2021

    The endocannabinoid system in the amygdala and modulation of fear

  126. 2021

    Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+7
  127. 2020

    A systematic review of cigarette smoking trajectories in adolescents

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisDepressão+2
  128. 2020

    A systematic review of physical activity, sedentary behavior, and substance use in adolescents and emerging adults

  129. 2020

    Adult attention-deficit hyperactivity disorder and clinical correlates of delayed sleep phase disorder

    DesfavorávelEnsaio ClínicoInsônia e Distúrbios do SonoTDA e TDAH
  130. 2020

    Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisDisfunção Cognitiva
  131. 2020

    Brief Behavioral Interventions for Substance Use in Adolescents: A Meta-analysis

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  132. 2020

    Cannabinol in the spotlight: Toxicometabolomic study and behavioral analysis of zebrafish embryos exposed to the unknown cannabinoid

  133. 2020

    Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDisfunção CognitivaEsquizofrenia+4
  134. 2020

    CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim

    FavorávelEstudo em AnimaisDepressãoDisfunção CognitivaTEPT
  135. 2020

    Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice

    FavorávelEstudo em AnimaisInflamaçãoDisfunção CognitivaDoenças Neurodegenerativas+1
  136. 2020

    Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy

    FavorávelEnsaio ClínicoEpilepsiaDisfunção CognitivaCBD Farmacêutico
  137. 2020

    Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance

  138. 2020

    Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity

  139. 2020

    Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone

  140. 2020

    Sales to apparently alcohol-intoxicated customers and online responsible vendor training in recreational cannabis stores in a randomized trial

  141. 2020

    The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

  142. 2019

    A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC

  143. 2019

    Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampus

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedade
  144. 2019

    Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDoenças Neurodegenerativas
  145. 2019

    Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study

    FavorávelEnsaio ClínicoAutismo
  146. 2019

    Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series

    FavorávelMetanáliseAnsiedadeDepressãoDisfunção Cognitiva+3
  147. 2019

    Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states

    InconclusivoEnsaio ClínicoDisfunção CognitivaPsicose
  148. 2019

    Cerebellar alterations in cannabis users: A systematic review

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+2
  149. 2019

    Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study

  150. 2019

    CNR1 and FAAH variation and affective states induced by marijuana smoking

    InconclusivoEnsaio ClínicoDependência — CannabisAnsiedade
  151. 2019

    Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxication

  152. 2019

    Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors

    InconclusivoEstudo em AnimaisAnsiedadeDepressãoDisfunção Cognitiva+1
  153. 2018

    Approach bias modification for cannabis use disorder: A proof-of-principle study

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  154. 2018

    Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis

  155. 2018

    Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome

  156. 2018

    Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses

  157. 2018

    Linalool bioactive properties and potential applicability in drug delivery systems

    FavorávelMetanáliseDorCâncerInflamaçãoMedicina Mente-Corpo+9
  158. 2018

    Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoAutismoPalmitoiletanolamida (PEA)
  159. 2018

    Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

  160. 2018

    Posttraumatic Stress Symptoms and Emerging Adult Sexual Minority Men: Implications for Assessment and Treatment of Childhood Sexual Abuse

    FavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+6
  161. 2017

    Influence of childhood trauma on diagnosis and substance use in first-episode psychosis

    DesfavorávelMetanáliseDependência QuímicaDependência — CannabisAnsiedade+7
  162. 2017

    Therapeutic Alliance, Client Need for Approval, and Perfectionism as Differential Moderators of Response to eHealth and Traditionally Delivered Treatments for Comorbid Depression and Substance Use Problems

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão+2
  163. 2016

    A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease

  164. 2016

    Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses

  165. 2016

    Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism

  166. 2016

    Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users

  167. 2016

    Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment

  168. 2016

    Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid

    FavorávelEstudo em AnimaisAutismoHidrolase de Amidas de Ácidos Graxos (FAAH)
  169. 2016

    Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series

  170. 2015

    Evidence for a Role of Adolescent Endocannabinoid Signaling in Regulating HPA Axis Stress Responsivity and Emotional Behavior Development.

    FavorávelMetanáliseAnandamida (AEA)Endocanabinoide (não especificado)+2
  171. 2015

    Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats

  172. 2015

    Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDisfunção CognitivaTHC Farmacêutico+3
  173. 2015

    Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDoença de AlzheimerDemênciaTetraidrocanabinol (THC)
  174. 2015

    The association between impulsivity and alcohol/drug use among prison inmates

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Opioides+5
  175. 2014

    Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.

  176. 2014

    Gluten and casein supplementation does not increase symptoms in children with autism spectrum disorder

    InconclusivoEnsaio Clínico Duplo-CegoAutismoProteína Ligadora de Ácidos Graxos (FABP)
  177. 2014

    Palmitoylethanolamide in CNS health and disease

  178. 2014

    Protective effects of geraniol (a monoterpene) in a diabetic neuropathy rat model: attenuation of behavioral impairments and biochemical perturbations

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoDoenças Neurodegenerativas+2
  179. 2014

    The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice

  180. 2014

    Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study

  181. 2013

    Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeDoenças Cardiovasculares (DCV)+7
  182. 2012

    A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury

  183. 2012

    Minireview: Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior.

    FavorávelMetanáliseEndocanabinoide (não especificado)
  184. 2012

    Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans

    InconclusivoEnsaio Clínico Duplo-CegoDorEfeitos Adversos da CannabisDependência — CannabisAnandamida (AEA)+4
  185. 2011

    Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents

    DesfavorávelMetanálise
  186. 2010

    A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

    FavorávelEstudo em AnimaisDorAnsiedadeDisfunção CognitivaTetraidrocanabinol (THC)+4
  187. 2009

    Bidirectional Regulation Of Novelty-induced Behavioral Inhibition By The Endocannabinoid System

  188. 2008

    Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats

    DesfavorávelEstudo em AnimaisGestaçãoTetraidrocanabinol (THC)
  189. 2008

    Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625

  190. 2007

    The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults

    DesfavorávelEnsaio Clínico Duplo-CegoDisfunção Cognitiva
  191. 2004

    Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice.

    InconclusivoEstudo em AnimaisAnsiedade
  192. 2002

    Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat

    DesfavorávelEstudo em AnimaisDisfunção CognitivaSíndrome MetabólicaCanabinoides Sintéticos SR-x

Continue por aqui

Perguntas frequentes

Quantos estudos sobre transtornos de comportamento estão indexados no acervo?
São 192 estudos, publicados entre 2002 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 84 · Estudo em Animais: 42 · Ensaio Clínico: 32 · Ensaio Clínico Duplo-Cego: 25 · Metanálise Clínica: 9. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 99 favoráveis, 38 inconclusivos e 55 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Transtornos de Comportamento — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/transtornos-de-comportamento/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Transtornos de Comportamento — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/transtornos-de-comportamento/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.